Brand Manager Cardiometabolic Health (m/w/d)

Eli Lilly Eli Lilly · Pharma · Bad Homburg, Germany

This role is for a Brand Manager in the Cardiometabolic Health division at Eli Lilly, focusing on a flagship Type-2-Diabetes brand in Germany. The position requires full end-to-end responsibility for brand strategy, planning, budget, execution, and performance, involving leadership of cross-functional teams and management of integrated, multichannel campaigns. The role demands strong commercial judgment, deep understanding of the German healthcare environment, and compliance with local regulations.

What you'd actually do

  1. Own the brand in Germany with full accountability for strategy, annual planning, budget, execution, and performance.
  2. Lead and align the cross-functional brand team (Medical Affairs, Market Access, Sales/KAM, Digital/CRM) towards shared strategic objectives.
  3. Lead the development and localisation of integrated, multichannel campaigns across digital, field force, congresses, and medical education.
  4. Own brand KPIs and performance tracking, providing clear, insight-driven updates and recommendations to senior leadership.
  5. Define clear, differentiated value propositions by customer segment, informed by market research, customer insights, and competitive intelligence.

Skills

Required

  • Degree in Marketing, Business, Life Sciences, or a related field
  • 3–5+ years of pharmaceutical or healthcare marketing experience
  • Demonstrated brand ownership and campaign delivery
  • Strong understanding of the German pharmaceutical market
  • Familiarity with AMNOG/G-BA processes and promotional regulations (HWG, FSA Kodex)
  • Proven ability to lead cross-functional teams
  • Experience managing complex stakeholder environments
  • Strong analytical mindset
  • Experience using market research and sales data (e.g. IQVIA/IMS)
  • Fluent German and English
  • Excellent communication and presentation skills

Nice to have

  • MBA or equivalent
  • Experience in diabetes, metabolic or cardiovascular disease
  • Familiarity in GLP-1 or incretin therapy dynamics
  • Experience working in a matrix organisation
  • People leadership or mentoring experience

What the JD emphasized

  • full end-to-end responsibility
  • strategic and operational owner of the brand
  • strategy, annual planning, budget, execution, and performance
  • positioning, messaging, channel mix, and investment priorities
  • value propositions by customer segment
  • commercial rigour
  • cross-functional brand team
  • primary brand decision-maker
  • German affiliate and global/IBU brand teams
  • value story is consistently embedded
  • integrated, multichannel campaigns
  • MLR review process
  • personalised, data-driven HCP engagement
  • high-quality outputs on time and within budget
  • brand KPIs and performance tracking
  • actionable insights
  • GLP-1 / dual-agonist dynamics
  • pharmaceutical or healthcare marketing experience with demonstrated brand ownership and campaign delivery
  • German pharmaceutical market
  • AMNOG/G-BA processes and promotional regulations (HWG, FSA Kodex)
  • market research and sales data
  • diabetes, metabolic or cardiovascular disease
  • matrix organisation